/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
allotted to specific persons (Private Placement), the Company shall be eligible to register the change of the paid-up capital with the Public Company Registrar periodically in line with the payments received
, more home cooking behaviors. The results of the expanding production line into flexible packaging group help reducing impact from uncontrollable external environmental risks for the company. Allowing the
special products with a focus on dine-in products to be in line with the easing government measures in preventing the spread of COVID-19 as previously the Company has focused mainly on the development of
1H16 was in line with the decrement in sales. The gross profit margin was 47%, higher than 2Q16 and 1Q17 due to the Company effort to carefully control marketing expenses. For 1H17, the gross profit
profit The increment cost of goods sold for 3Q17 compared with 3Q16 and 2Q17 were in line with the increment in sales. The Company held more events such as “FN Fair” at head office and “FN Thank you sale
* According to the adoption of Thai Financial Reporting Standard No.9 Financial Instruments since January 1, 2020, the Company reclassified loan from financial institution for the MRT Purple Line Project (the
- Vietnam • Cost of electricity purchased from subsidiaries of EVN remained unchanged year-on-year at Baht 793 million for 9M’2017 in line with change in electricity sales to industrial users in Vietnam. O&M
linked to tourism and the export sector. In contrast, consumer spending in some provinces linked to the agricultural sector continued to decelerate in line with lower farm income due to the low price of